Kevin Kinsella

Kevin Kinsella Overview

  • Investor Type
  • Angel
  • Investments
  • 3
  • Portfolio
  • 2
  • Exits
  • 1

Kevin Kinsella General Information


Mr. Kevin Kinsella is a Co-Founder of Avalon Ventures. He serves as a Board Member at Eikonizo Therapeutics. He serves as Board Member at Ankasa. He served as Board Member at Avelas Biosciences. He is a Board Member at Jnana Therapeutics. He co-founded HauteDecor and served as its Chairman. He was the Founding Chairman at Landmark Graphics. He has specialized in the formation, financing, and development of more than 100 early-stage companies, including Athena Neurosciences Onyx Pharmaceuticals, Sequana, Vertex Pharmaceuticals, Synaptics, Vocera Communications, Amira Pharmaceuticals, Cardeas Pharma and Juliet Marine Systems. Mr. Kinsella was the founding chairman of Athena Neurosciences, Aurora Biosciences, Landmark Graphics, NeoRx, Onyx Pharmaceuticals, Synaptics, Vertex Pharmaceuticals, X-Ceptor, and Sequana Therapeutics. Prior to founding Avalon, Mr. Kinsella worked for Solar Turbines International (Caterpillar Tractor) where he was in charge of all international joint ventures, barter, and counter-trade. Previously, he was an advisor to the Peruvian government in National Nutrition Planning, ran a technology exchange program between the U.S. and Latin America based in Mexico City and taught algebra at the American High School in Beirut, Lebanon. He was also a guest op-ed columnist for the Boston Herald American. Mr. Kinsella is a graduate of the Massachusetts Institute of Technology ("MIT") with a Bachelor of Science degree in management, with minors in electrical engineering and political science. He holds a Master of Arts degree in international relations from the Johns Hopkins School of Advanced International Studies and conducted post-graduate work in political economy on a Rotary International Fellowship at the University of Stockholm, Sweden. Mr. Kinsella is a member of the Board of Directors of Cardeas Pharma. He also serves as Board Member at Juliet Marine Systems.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 1134 Kline Street
  • La Jolla
  • San Diego, CA 92037
  • United States
+1 (858) 000-0000

Kevin Kinsella Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Eikonizo Therapeutics 16-May-2018 Seed Round 000 Drug Discovery Pre-Clinical Trials 00000 00000000
000000 01-Aug-2000 00000 00000 0000 Software Development Applications Generating Revenue 00000 00000000
000000000 10-Apr-2000 00000 (00000 000 Application Software Generating Revenue 00000 00000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kevin Kinsella Exits (1)

To view Kevin Kinsella‘s complete exit history, request access »
Company Name Exit Date Exit Type Exit Size
000000 30-Jul-2003 000000000000000000

Kevin Kinsella Team (1)

Name Title Deals Funds Boards Office
Kevin Kinsella Angel Investor 00 0 0 San Diego, CA

Kevin Kinsella Co-Investors (2)

To view Kevin Kinsella‘s complete co-investor history, request access »
Name With Exits Lead Partner Series Industry
Alzheimers Drug Discovery Foundation 1 0 Series chart Industry bar
F-Prime Capital 0 0 Series chart Industry bar